Drug Shortage Report for ACT-HIB

Last updated on 2021-11-26 History
Report ID 149904
Drug Identification Number 01959034
Brand name ACT-HIB
Common or Proper name Haemophilus b Conjugate Vaccine (Tetanus Protein - Conjugate)
Company Name SANOFI PASTEUR LIMITED
Market Status MARKETED
Active Ingredient(s) TETANUS PROTEIN HAEMOPHILUS INFLUENZAE TYPE B-PRP
Strength(s) 30MCG 10MCG
Dosage form(s) POWDER FOR SOLUTION KIT
Route of administration INTRAMUSCULAR INTRAMUSCULAR
Packaging size 5 x 0.5 mL vials
ATC code J07AG
ATC description BACTERIAL VACCINES
Reason for shortage Delay in shipping of the drug.
Anticipated start date 2021-11-25
Actual start date
Estimated end date 2021-12-09
Actual end date
Shortage status Actual shortage
Updated date 2021-11-26
Company comments Delay in shipment of identity test samples
Health Canada comments
Contact Address 1755 STEELES AVENUE WEST
TORONTO, ONTARIO
CANADA M2R 3T4
Company contact information Customer Service/Service à la clientèle: 1-800-268-4171 Vaccine Information Service/Service d'information sur les vaccins: 416-667-2611 or 1-888-621-1146

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v3 2021-11-26 English Compare
v2 2021-11-25 French Compare
v1 2021-11-25 English Compare